Haley is our dedicated Communications Director and Graphic Designer. She’s a proud native of Minnesota and graduated with her Bachelors in Creative Arts and Graphic Design at Metropolitan State University. In her free time, she likes to freelance design, listen to vinyl records, cook gourmet food, and spend time with her family. Her strong sense of intuition, creativity, and her ability to appreciate the little things in life is what got her interested in design. Her job at Team Telomere as the Graphic Designer encompasses all the those qualities to create beautiful designs for a community that matters!

Kendall is a driven health advocacy professional with strong community outreach, patient association, health care provider, rare disease and chronic illness expertise. Kendall Davis recently joined the Rare Disease Center of Excellence at PRA Health Science to ensure that the patient voice is not only heard but considered and utilized in the clinical research lifecycle. Kendall previously served as the Director of Strategic Alliances at Global Genes, a leading rare disease patient advocacy organization and has held key roles in patient advocacy and patient education in both the nonprofit and biopharmaceutical industries. Kendall’s passion is to improve the health outcomes of individuals living with rare diseases while creating strategic advocacy and awareness campaigns in the rare diseases space. Kendall specializes in cultivating partnerships with patient advocacy organizations, identifying and partnering with Key Opinion and Community Leaders, identifying key business needs, developing customized programs to achieve key outcomes and balancing a global focus with national, regional and local patient centric partnerships. Kendall works with leaders in the rare disease nonprofit community and biotechnology space to advance progress in the rare disease community.

Kendall holds a Master’s Degree of Public Health from Michigan State University as well as a Bachelor’s of Science in Psychology from Loyola University, Chicago.

Heather Kagel lives in Dallas Texas and has been engage with Team Telomere since 2018. Heather has a TERC gene mutation and short telomeres. She was diagnosed with Idiopathic Pulmonary Fibrosis in 2013 and Oral Squamous Cell Carcinoma in 2016. Thanks to a wonderful organ donor, she recently received a double lung transplant! Heather brings her personal experience and a passion for more education and raising awareness of these telomere biology disorders and their accompanying diseases.

Heather lives with her husband Rick and their shih-tzu Huckleberry. Her two children, Mitchell (23) and Samantha (22) are living away from home but continue to be amazing care partners and supporters. Heather enjoys travelling (especially to the beach!!), baking, and paper crafts.

Jeni Colter was previously a member of Team Telomere’s Outreach committee before joining the board in September 2019. Her daughter, Megan, now 18, was diagnosed in 2016 through genetic testing revealing a novel variant on the TERT gene as well as very short telomeres. Jeni was later found to have the same variant and very short telomeres. Their family attended Camp Sunshine in 2016 and fell in love with the DC Outreach/Team Telomere community. Jeni was diagnosed at 19 with Multiple Sclerosis, giving her many years of practice navigating the many aspects of life with a chronic illness.

Her professional background is in early childhood education. She taught preschool for 15 years before leaving her position last year. She happily lives in Laramie, Wyoming enjoying the beauty of the mountains. She has been happily married for 27 years to  Dr. Rob Colter, Ph.D., a faculty member in the Department of Philosophy and Religious Studies at the University of Wyoming,  In addition to Megan, she has a son Jackson, 25, who is completing his master’s degree in Philosophy at Colorado State University. In addition to their human children, they have two spoiled rotten dogs, Athena and Gus. One of her goals while serving on the board is to broaden the resources available to the young adult population living with DC. 

Allison Kiene joined the board of Team Telomere in October 2019.  Allison is from South Windsor, Connecticut and currently resides in Somers, New York. She has two children, Tim (28) and Caitlin (24).  In 2005, Allison’s two brothers, Robert and Richard, were diagnosed with aplastic anemia secondary to Dyskeratosis Congenita and genetic testing revealed that Allison and her mom were both carriers of the disease.  Robert and Richard received stem cell transplants under the care of Dr. Joseph Antin and Dana-Farber Cancer Institute.  At the time, there were very few resources available to the family and limited understanding of the disease and what would come next.   Initially, it appeared that Robert was “cured” only to learn shortly after the transplant that he had Pulmonary Fibrosis.  In 2008, at the age of 36, Robert succumbed to the disease.  Richard would carry-on earning his doctorate in organic chemistry, marrying his best friend (Ashley) and beginning his career as a college professor.  Richard lived life to its fullest fighting each obstacle the disease put before him.  In 2015, both Allison’s mom (71) and Richard (36) passed away from Pulmonary Fibrosis. 

Allison became a member of the Team Telomere community because she values and understands first-hand the need to support families battling Dyskeratosis Congenita and related diseases.  Allison serves as Senior Vice President, Assistant General Counsel and Chief Compliance Officer for Sompo International, a global property and casualty insurance and reinsurance company.  Allison is admitted to the Bar in Connecticut, Massachusetts and New York and holds pharmacy licenses in Connecticut and New York.

Hannah Raj lives in the greater Chicagoland area. She became involved with Team Telomere after first-handedly learning about Telomere Biology Disorders at the start of 2020. From the very beginning of her journey, Team Telomere’s community and resources made her feel truly supported and connected. Her goal is that every person affected by Telomere Biology Disorders feels the same way. The small contributions she has made to the community thus far have been her greatest joy. Using her personal and professional experiences, she is excited to wholeheartedly and passionately serve, advocate for, and further the research for the Team Telomere community. Hannah is especially driven to supporting and connecting with young adults and children impacted by Telomere Biology Disorders. She is always a call, email, or message away from connecting with the community!

In her free time, she enjoys playing the piano and spending time with her family and friends. Hannah received her Bachelor’s Degree in Neuroscience in 2021 from the University of Illinois at Chicago, and she hopes to continue her education by pursuing a medical degree.

Nicole lives in southern Minnesota has been a part of the DC community since the very beginning in 2008. She has been married to Logan for 24 years. She has two children, Rilee and Jordyn, and came to this community because of her daughter Rilee. Rilee was affected by DC and had a successful BMT in 2003 at the age of 3. In 2015 she started having lung, liver, and GI issues. Ultimately, GI bleeding took her life in March of 2017 at the age of 17. Rilee’s creativity has inspired Nicole to put her whole heart into the community. She comes with much knowledge and personal experience and brings her heart and passion with her. She has already been giving her time behind the scenes for the last few years and looks forward to serving our rare community in a leadership role.

Ryan joined the board for Team Telomere in September 2018 and was elected into the Treasurer’s Seat in December 2018. Ryan was first introduced to the Team Telomere community through Camp Sunshine in 2016 and has been an avid supporter since. He lives in New York City and is an ETF Strategist for QQQ at Invesco. He has an extensive background in finance, having a BA in Economics from Johns Hopkins University and a long working history with OppenheimerFunds, Merrill Lynch and Morgan Stanley. When he’s not working, Ryan enjoys spending time outdoors: skiing, playing sports and hiking. He also enjoys traveling and spending time with his family on Long Island.

Eric Villeneuve joined Team Telomere in 2018 and currently resides in Durham, North Carolina. He possess a Master’s in Public Health from the University of Pennsylvania and during his graduate program, Eric became involved with Team Telomere while participating as a member of a student led healthcare consulting firm. He works for RTI International as a social science researcher in the Center for Youth, Violence Prevention and Community Justice. His skillset brings a unique approach to criminal justice research by incorporating a public health approach to complex criminal justice problems. He plans to use the expertise gained during his multiple experiences to enhance patient outreach and assistance to better the lives of those suffering with telomere biology disorders.

Heidi Carson lives and works in Silicon Valley. She is connected to Team Telomere through her husband, Chad, who passed away in 2019 due to complications from a bone marrow transplant following a liver transplant that tried to address the health issues caused by his very short telomeres. Heidi is working on several projects with Team Telomere with the dream goal of helping this community develop better treatments and ultimately one day a cure for telomere biology disorders. As Team Telomere’s Data Collection Program Manager, she is currently building a platform for patients and researchers to collaborate and share data. Heidi is also happy to share her experiences navigating telomere disease as a primary caregiver – please feel free to reach out. Heidi lives with her two teenage children and their rescue dog and enjoys traveling, yoga, and learning languages.

Dr. Mrinal Patnaik is an Associate Professor of Internal Medicine at the Mayo Clinic, Division of Hematology, in Rochester, Minnesota. He is affiliated with the Myeloid Malignancies group and is the director of the precision genomics practice. He is the co-director of the Epigenetics Developmental Laboratory and an executive member for the Beyond DNA committee, a major directive of the Center for Individualized Medicine. He obtained his medical degree from the Grant Medical College in Mumbai and then did his Internal Medicine residency at the University of Minnesota. He then completed a fellowship in Hematology, Oncology and BMT at the Mayo Clinic and has been a faculty member ever since. He has a strong interest in bone marrow failure syndromes and in 2017, with the help of the Division of Hematology and the Center for Individualized Medicine, he launched the program for excellence for Telomere Biology Disorders. This is a multidisciplinary clinical and laboratory effort being carried out to assess and provide comprehensive care to patients with Telomere Biology Disorders, including Dyskeratosis Congenita. His research interests include assessing for clonal hematopoiesis in Telomere Biology Disorders, epigenetic regulation of telomere length and the development of clinical trials for patients with Telomere Biology Disorders.

1. Dr. Bertuch received her BS from Massachusetts Institute of Technology and her MD and PhD from University of Rochester. She then completed her residency in Pediatrics and fellowship in Pediatric Hematology/Oncology at Baylor College of Medicine in Houston, Texas, where she has remained and is currently Professor of Pediatrics, in the Division of Hematology/Oncology, and Molecular & Human Genetics. She is the Director of the Bone Marrow Failure Program at Texas Children’s Hospital, where she cares for children with a wide range of conditions, including the Telomere Biology Disorders (TBDs). Dr. Bertuch has a long-standing interest in the TBDs and her research contributions have spanned from the basic science of telomeres to translational and clinical studies. She is particularly interested in the complexity of the molecular genetics underlying these disorders. Her research has been funded by the National Institutes of Health, the Department of Defense Bone Marrow Failure Research Program and the American Society of Hematology. She has received several honors including election to the American Society for Clinical Investigation and the American Pediatric Society.

Hello, I’m Rachel Little from Queensland, Australia.

I have been a photographer and an early childhood educator, but my most passionate role is being a wife and mother of two boys. Cooper is our angel, watching over from above, and Grayson (1yo) is our warrior on earth, diagnosed with Hoyerall-Hreidarsson Syndrome.

Being so rare, I dove head first into study to understand it all as best as I could, considering all of our doctors had barely (some never) heard about DC or HHS before. I felt I had to understand it all, incase they didn’t – for my sons sake!

I was pleasantly surprised, and relieved, to find myself welcomed into the village of Team Telomere!

Grayson has two TERT gene mutations, one each passed on from myself and my husband, Leighton. We still can’t fathom the odds of us both having the same gene mutation, but I guess it means we were meant to be together! We are still unsure of the implications this will have on ourselves being a carrier, but for now our priority is getting Grayson through his Bone Marrow Transplant.

I am so excited to join Team Telomere to help spread awareness, fundraise for research and connect with families effected by TBD/DC.
I am passionate about getting the global awareness needed to fund more research into telomere studies and find our warriors a cure!

Seine Ausbildung zum Kinderonkologen erhielt Herr Prof. Kratz an der Albert-Ludwigs-Universität Freiburg, wo er habilitierte und zum Oberarzt ernannt wurde. Es folgten Tätigkeiten in Wellington, Neuseeland und am National Cancer Instistute in Bethesda, Maryland, USA. Im Jahre 2012 erhielt er den Ruf auf die W3-Professur für Pädiatrische Hämatologie und Onkologie an der MHH. Sein Forschungsschwerpunkt liegt im Bereich der Erforschung von Krebsursachen bei Kindern. Insbesondere setzt er sich in seinen klinischen Tätigkeiten und auch in seiner Forschung für Menschen mit einem erhöhten Krebsrisiko ein, wie für Menschen mit Dyskeratosis congenita.

Rosario Perona Abellón es profesor de Investigación del Consejo Superior de Investigaciones Cientificas. Actualmente es jefe de grupo en el Instituto de Investigaciones Biomédicas (CSIC/UAM) y dirige el grupo de Enfermedades con defectos en telómeros U757 en el CIBER de enfermedades raras (CIBERER).  Su grupo esta especializado en el estudio genético de pacientes con disqueratosis congenita y fibrosis pulmonar idiopática y es el grupo de referencia en España para el estudio de ambas enfermedades. Actualmente tambien trabaja en el desarrollo de una terapia de reactivación de telomerasa  basada en la actividad del péptido GSE4.

Rosario Perona Abellón é Professor do Investigação do Conselho Superior de Investigações Científicas. Atualmente é líder do grupo no Instituto de Investigações Biomédicas (CSIC / UAM) e dirige o grupo de doenças com defeitos nos telômeros U757 no CIBER de doenças raras (CIBERER). Seu grupo é especializado no estudo genético de pacientes com disqueratose congênita e fibrose pulmonar idiopática e é o grupo de referência para o estudo de ambas as doenças. Atualmente, ele também está trabalhando no desenvolvimento de uma terapia de reativação da telomerase para ambas as doenças com base na atividade de um peptídeo GSE4.

Carlo Dufour lavora presso l’Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) G. Gaslini di Genova, il più grande ospedale pediatrico multi specialistico del paese, dove è dirige il Polo emato – oncologico – trapianto di cellule staminali ematopoietiche, e l’Unità di Ematologia che è  sede  del Registro Nazionale delle Neutropenie, del Registro Nazionale Alps e delle malattie correlate, del database nazionale dell’Anemia di Fanconi e del neofondato Registro Italiano Telomeropatie. Ha fondato, nell ‘Associazione Italiana di Ematologia Oncologica Pediatrica (AIEOP), il Gruppo di Studio sulle Sindromi da Insufficienza Midollare. Membro del network  internazionale TeamTelomere, attivo sulle malattie da disfunzione del telomero.  E’ autore o co-autore di più di 200 pubblicazioni internazionali e di libri di testo e capitoli di libri di ematologia. E’ revisore delle più importanti riviste scientifiche internazionali far cui : New England Journal of Medicine, Journal of Clinical Oncology, Leukemia, Clinical Immunology e Blood. Ha operato come valutatore esperto di progetti e contributi scientifici per vari istituzioni internazionali fra cui il Registro Francesce per le malattie rare,  Fanconi Anemia Research Fund INC (US), Leukemia and Lymphoma Research Foundation (UK),  American Society of Hematology Education Program. É stato Chairman del  Working Party of the Severe Aplastic Anemia (WPSAA) e membro del Bord dell’ European Society for Blood and Marrow Transplantation (EBMT). Al momento  ricopre il ruolo di coordinatore  dello Scientific Working Group (SWG)  on Granulocyte and Constitutional Marrow Failure Disorders per la European Hematology Association (EHA). All’interno dell’EHA fa parte della’ SWG Unti, dell’Eucational Committee e del Comitato per le Linee Guida. Ha partecipato alla commissione per l’attribuzione delle cattedre di medicina molecolare della University of London.

Da Dicembre 2019 è membro del Scientific Committee of the American Society of Hematology.

Nel 2015 ha ricevuto dal  Fanconi Anemia Research Fund. INC (FARF) il Discovery Award per la partecipazione all’identificazione del gene FANCT.

Nel dicembre 2019 gli è stato riconosciuto il premio per il contributo scientifico nel campo dell’Anemia di Fanconi dalla spagnola “Fundacion en la Anemia de Fanconi”.

A inizio 2020 è stato premiato dalla European Society of Blood and Marrow Transplantation (EBMT) con il Premio Van Bekkum, riconoscimento riservato al miglior contributo scientifico dell’anno, per lo studio prospettico randomizzato RACE (Confronto fra Immunosoppressione classica  ± Eltombopag)  nei pazienti con anemia aplastica grave.